Why settle for tech transfer when you can sell direct?


Published September 13, 2024
Technology
Category

At the Special Edition Virtual Pub, “Innovation in Imaging,” we will discuss some of the issues that innovators should be aware of and hear use cases from our network about successful tech transfer and translation from the lab.

When: September 27, 2024, from 13:00-15:30 CEST

Where: Online

At this event, Ed Mitchell (ESRF), will explore the pros and cons of internal approach to technology development and manufacturing in a presentation entitled, “Why settle for tech transfer when you can sell direct?” 

Full program
Register

WhY SETTLE FOR TECh transfer when you can sell direct?

Ed Mitchell, ESRF

Abstract

In today’s rapidly evolving innovation landscape, research institutions can face a critical decision: should they transfer their technology to external partners or develop and commercialise it internally? An internal approach can maximise financial returns and visibility of the facility concerned, but involves manufacture of the products in-house with the risks and effort that this requires. This presentation will be a rapid perspective on the pros and cons of bypassing traditional technology transfer and adopting an in-house development and commercialization approach, leveraging facility expertise and resources to directly bring products to market.


More news from Euro-BioImaging

Junel Solis, Finish Advanced Microscopy Node, at work analysing microscope data.

July 24, 2025

Meet Junel Solis, Head Image Data Analyst at the Finnish Advanced Microscopy Node

As part of our ongoing series spotlighting the talented scientists working at the Euro-BioImaging Nodes, we sat down with Junel Solis, an expert in…

Looking at the neuronal cells in the hydrogel with two-photon microscopy. 

July 21, 2025

International collaboration to support Parkinson’s disease research

Would learning to use the most cutting-edge imaging instruments help you answer your scientific question? Could world-class technology accelerate your research? We spoke to…

Telemedicine and human Bladder recovery concept. Neutral color palette, copy space for text.

July 21, 2025

PHIRE: a photoacoustic imaging and AI-based theranostic approach for cancer

Bladder cancer is the 10th most common cancer globally, with more than half million new cases every year, but it is the most expensive…